PMID: 3755516Sep 1, 1986Paper

Prevention of intraventricular hemorrhage in very low birth weight infants by maternally administered phenobarbital

Obstetrics and Gynecology
W J Morales, J Koerten

Abstract

One hundred fifty pregnant women destined to deliver infants less than 32 weeks were randomly assigned to two groups. One group received phenobarbital in doses sufficient to achieve blood levels of 15 to 40 micrograms/mL, and this level was maintained in the neonate after birth. The second group received no antenatal treatment, but the infants were treated with phenobarbital after birth for at least four days. The infants were followed with ultrasound examinations of the head on postnatal days 1, 4, and 10 to assess the grade and progression of intraventricular hemorrhage. Intraventricular hemorrhage was significantly less frequent in the experimental group, 16 of 75 (21%) versus 35 of 75 (47%), P less than .01. Similarly, the experimental group had significantly fewer cases of severe intraventricular hemorrhage (grades III and IV), four of 75 (5%) versus 15 of 75 (20%), P less than .05 and mortality three of 75 (4%) versus ten of 75 (13%), P less than .05. Maternally administered phenobarbital appears to be effective in reducing the incidence of intraventricular hemorrhage and lessening its severity.

Citations

Jul 12, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Luigi MatturriAnna M Lavezzi
Jan 1, 1993·Pharmacology & Therapeutics·W F Rayburn, G G Payne
Aug 18, 1995·Early Human Development·J T Wells, L R Ment
Jan 5, 1996·Early Human Development·B Vohr, L R Ment
Jun 1, 1997·Obstetrics and Gynecology·J A ThorpM Poskin
Feb 1, 1997·Pediatric Clinics of North America·A A Rosenberg, H L Galan
Dec 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A H SchaapP E Treffers
Apr 4, 2002·Drugs·Gideon KorenArne Ohlsson
Sep 1, 1988·American Journal of Obstetrics and Gynecology·W J MoralesF Marsalisi
Feb 1, 1993·American Journal of Obstetrics and Gynecology·W J Morales, T Talley
Sep 11, 1992·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·D J SalaL Cordella-Simon
Jun 1, 1992·Pediatric Annals·R N Ichord
Sep 27, 2003·Seminars in Perinatology·Marya Strand, Alan H Jobe
Sep 1, 1993·Baillière's Clinical Obstetrics and Gynaecology·W J Morales
Jan 1, 1991·Annals of Emergency Medicine·A Jagoda, S Riggio
Oct 20, 2001·American Journal of Obstetrics and Gynecology·J A ThorpJ L Peabody
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Seetha ShankaranJoel Verter
Jan 8, 2000·Research in Nursing & Health·G C McCainP Gartside
Aug 1, 1990·Early Human Development·C StrandC R Rosenfeld
Aug 1, 1990·Early Human Development·L A WallinR E Lasky
Mar 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L C Evans, C A Combs
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Caroline A CrowtherDavid J Henderson-Smart
Jul 1, 1992·Paediatric and Perinatal Epidemiology·M O'SheaK A Feinstein
Dec 1, 1991·DICP : the Annals of Pharmacotherapy·K C Lamp, M S Reynolds
Jun 1, 1991·Scottish Medical Journal·D M Newnham, D P Dhillon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.